Mertonin
Mertonin is a synthetic opioid analgesic developed by the pharmaceutical company Endo Pharmaceuticals. It was approved by the U.S. Food and Drug Administration (FDA) in 2006 for the management of moderate to severe pain. Mertonin is a mu-opioid receptor agonist, which means it binds to the mu-opioid receptors in the brain and spinal cord to produce its analgesic effects. It is available in oral tablet form and is typically prescribed for chronic pain conditions such as cancer pain, osteoarthritis, and chronic low back pain.
Mertonin is known for its relatively short duration of action, with peak effects occurring within 1 to
Mertonin is not approved for use in the United Kingdom or many other countries due to concerns
In summary, mertonin is an opioid analgesic used to manage moderate to severe chronic pain. It offers